Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10454886 | 1.00 | AKR1C3 (0.59) | AKR1C3GLATDP1GAAMAOB | |
| SCHEMBL16462 | 1.00 | AKR1C3 (0.59) | AKR1C3GLATDP1GAAMAOB | |
| Methacrylic Acid SCHEMBL5875032 | 0.93 | AKR1C3 (0.52) | AKR1C3GLATDP1GAAMAOB | |
| Butadiene SCHEMBL9678114 | 0.93 | AKR1C3 (0.52) | AKR1C3GLATDP1GAAMAOB | |
| Maleic Acid SCHEMBL8981883 | 0.93 | HDAC3 (0.55) | AKR1C3GLATDP1GAAMAOB | |
| Ethylene Glycol SCHEMBL10395022 | 0.93 | AKR1C3 (0.52) | AKR1C3GLATDP1GAAMAOB | |
| SCHEMBL28318920 | 0.93 | AKR1C3 (0.52) | AKR1C3GLATDP1GAAMAOB | |
| SCHEMBL27283330 | 0.92 | AKR1C3 (0.55) | AKR1C3GLATDP1GAAMAOB | |
| Acrylic Acid SCHEMBL448096 | 0.91 | AKR1C3 (0.50) | AKR1C3GLATDP1GAAMAOB | |
| Styrene SCHEMBL451196 | 0.91 | AKR1C3 (0.50) | AKR1C3GLATDP1GAAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0454980-B1 | Encapsulated toners and processes thereof | XEROX CORP (US) | 1998-08-05 | — | — | EP | claimed |
| EP-0460510-B1 | Toner and developer compositions with charge enhancing additive | XEROX CORP (US) | 1996-04-24 | — | — | EP | claimed |
| JP-1144402-A | — | — | None | — | — | JP | disclosed |
| EP-3019443-B1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION SENSITIVE FLUORESCENT PROBES | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIV WASHINGTON (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447469-B2 | Methods and apparatus for single biological nanoparticle analysis | UNIVERSITY OF WASHINGTON (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250290930-A1 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2025-09-18 | — | — | US | disclosed |
| EP-3483610-B1 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | UNIV OF WASHINGTON CENTER FOR COMMERCIALIZATION (US) | 2025-09-10 | — | — | EP | disclosed |
| US-12352754-B2 | Functionalized chromophoric polymer dots and bioconjugates thereof | UNIVERSITY OF WASHINGTON (US) | 2025-07-08 | — | — | US | disclosed |
| CN-112105912-B | Method and apparatus for single biological nanoparticle analysis | 华盛顿大学 | 2025-05-23 | — | — | CN | disclosed |
| EP-3543207-B1 | WESTERN BLOT ANALYSIS USING POLYMER DOTS | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2025-04-23 | — | — | EP | disclosed |
| US-5911899-A | Corrosion-proof transparent heater panels and preparation process thereof | MITSUI CHEMICALS, INC. (JP) | 1999-06-15 | — | — | US | disclosed |
| EP-0494842-B1 | Rigid contact lenses with improved oxygen permeability | CIBA GEIGY AG (CH) | 1998-04-22 | — | — | EP | disclosed |
| EP-0749266-A2 | Transparent heater panels and method of making them | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0633918-A1 | ULTRAVIOLET RADIATION CURABLE ACRYLATE PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020164-A1 | ULTRAVIOLET RADIATION CURABLE ACRYLATE PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-10-14 | — | — | WO | disclosed |
| US-5194556-A | Macromolecular monomer derived from polysiloxane copolymerized with fluoroacrylate | CIBA-GEIGY CORPORATION (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0494842-A2 | Rigid contact lenses with improved oxygen permeability | CIBA-GEIGY AG (CH) | 1992-07-15 | — | — | EP | disclosed |
| US-4950467-A | SUNSCREEN AGENT CONTAINING 5-PHENYL-PENTADIENOATE ESTER | ICI AMERICAS INC. (US) | 1990-08-21 | — | — | US | disclosed |
| JP-H01144402-A | NON-AQUEOUS DISPERSION POLYMERIZATION | BAFFORD RICHARD A | 1989-06-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | CD63, SELL, LAMP2 | AKR1C3 4776/4885GLA 2820/4885TDP1 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.